Selank

People run it for anxiety relief and a clearer head — a takes-the-edge-off calm that, unlike sedatives, isn't supposed to dull you. The most-repeated experience is fast onset: a noticeable settling within minutes to half an hour of a nasal spray, lasting a few hours. Secondary, people report steadier focus and better stress tolerance on busy days.

The signature claim — repeated in nearly every community discussion — is that small human trials put its anxiolysis in the same range as benzodiazepines, but without the dependence and withdrawal that define that class. That's the whole appeal: people describe getting the calm without feeling sedated or hooked. The other recurring theme is how fast it hits intranasally — the nose-to-brain route means many feel it almost immediately, which is why the injectable version is often just mixed into a nasal bottle instead.

A synthetic analog of the immune peptide tuftsin, modified to resist breakdown so it lasts long enough to act. It doesn't bind GABA-A receptors directly the way benzodiazepines do; the proposed mechanism is indirect — slowing the breakdown of enkephalins, nudging GABAergic and BDNF gene expression, and modulating serotonin and immune signaling. Important caveat: almost all of that mechanistic detail comes from rat and cell studies, not human work.

→ How to make a Selank nasal spray

Selank is described as very well tolerated, and the small human trials reported few adverse effects. What people do report is mild and transient: nasal irritation or dryness from the spray, a mild headache (most often from overspraying), and occasional fatigue. With subcutaneous use there can be local redness at the injection site. The honest gap is long-term safety data — there simply isn't much, so 'well tolerated' rests on short studies and community use, not years of follow-up.

Its classic pairing is with Semax — the two get run together so often they're treated as a set: Selank for the anxiety/calm side, Semax for focus and drive. Beyond that, people fold it into broader nootropic stacks. The one caution that comes up is combining it with serotonergic drugs (like SSRIs), where people flag a theoretical serotonin-overlap risk and advise medical oversight.